Brief: Neuronetics Announces Clinical Presence At The 2025 Clinical TMS Society Annual Meeting And Progress In Greenbrook's Personalized Care Trial Program
10/06/2025 15:10
June 10 (Reuters) - Neuronetics Inc STIM.O: NEURONETICS ANNOUNCES CLINICAL PRESENCE AT THE 2025 CLINICAL TMS SOCIETY ANNUAL MEETING AND PROGRESS IN GREENBROOK’S PERSONALIZED CARE TRIAL PROGRAM Source text: ID:nGNX6RWHFz Further company coverage: STIM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuronetics
See all newsNeuronetics Inc reports results for the quarter ended June 30 - Earnings Summary
Neuronetics Q2 revenue beats estimates on Greenbrook clinic strength
Neuronetics Inc expected to post a loss of 12 cents a share - Earnings Preview
Brief: Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
Brief: Neuronetics Appoints Nir Naor Chief Financial Officer Announces Additional Management Changes